相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas
Brunangelo Falini et al.
LEUKEMIA (2023)
Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature
Renata Woroniecka et al.
PLOS ONE (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio et al.
LEUKEMIA (2022)
Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with MYC and MYC/BCL2 rearrangements, especially in germinal center cell-type tumors
Jennifer Chapman et al.
LEUKEMIA & LYMPHOMA (2021)
Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas
Ivonne Vazquez et al.
VIRCHOWS ARCHIV (2021)
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit
Francesco Cucco et al.
LEUKEMIA (2020)
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas
Ivonne Vazquez et al.
CANCERS (2020)
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH
Laura K. Hilton et al.
BLOOD (2019)
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL
Salma Parvin et al.
CANCER CELL (2019)
A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
Yifei Liu et al.
DIAGNOSTIC PATHOLOGY (2019)
Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma-a feasibility study using full slide staining
Sarah Reinke et al.
VIRCHOWS ARCHIV (2018)
Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data
Xibiao Ye et al.
BMJ OPEN (2017)
LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas
Luis Colomo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2015)
Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists
Amer Z. Mahmoud et al.
MODERN PATHOLOGY (2015)
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Alexandra Valera et al.
HAEMATOLOGICA (2013)
MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection
Ana M. Munoz-Marmol et al.
HISTOPATHOLOGY (2013)
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma
Elena Cubedo et al.
BLOOD (2012)
Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma staining
Charles H. Lawrie et al.
HISTOPATHOLOGY (2012)
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
Kerry J. Savage et al.
BLOOD (2009)
LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
Yasodha Natkunam et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: Validation of tissue microarray as a prerequisite for broad clinical applications - A study from the Lunenburg Lymphoma Biomarker Consortium
Daphne de Jong et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue
Roland A. Ventura et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma
YL Zu et al.
LEUKEMIA & LYMPHOMA (2005)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
分享论文
